• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氟尿嘧啶联合光动力疗法:在光化性角化病小鼠模型中增强固有和适应性免疫应答。

Combination of 5-Fluorouracil with Photodynamic Therapy: Enhancement of Innate and Adaptive Immune Responses in a Murine Model of Actinic Keratosis.

机构信息

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Dermatology and Plastic Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.

出版信息

Photochem Photobiol. 2023 Mar;99(2):437-447. doi: 10.1111/php.13706. Epub 2022 Sep 20.

DOI:10.1111/php.13706
PMID:36039609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10319084/
Abstract

We previously showed that a combination of differentiation-inducing agents (5-fluorouracil [5FU], vitamin D3 or methotrexate) and aminolevulinate-based photodynamic therapy (PDT) improves clinical responses by enhancing protoporphyrin IX (PpIX) photosensitizer levels and cell death. Here, we show that in addition to its previously known effects, 5FU enhances PDT-induced tumor-regressing immunity. Murine actinic keratoses were treated with topical 5FU or vehicle for 3 days prior to aminolevulinic acid application, followed by blue light illumination (~417 nm). Lesions were harvested for time-course analyses of innate immune cell recruitment into lesions, i.e. neutrophils (Ly6G+) and macrophages (F4/80+), which peaked at 72 h and 1 week post-PDT, respectively, and were greater in 5FU-treated lesions. Enhanced infiltration of activated T cells (CD3+) throughout the time course, and of cytotoxic T cells (CD8+) at 1-2 weeks post-PDT, also occurred in 5FU-treated lesions. 5FU pretreatment reduced the presence of cells expressing the immune checkpoint marker PD-1 at ~72 h post-PDT, favoring cytotoxic T cell activity. A combination of 5FU and PDT, each individually known to induce long-term tumor-targeting immune responses in addition to their more immediate effects on cancer cells, may synergize to provide better management of squamous precancers.

摘要

我们之前曾表明,诱导分化剂(5-氟尿嘧啶[5FU]、维生素 D3 或甲氨蝶呤)和氨基酮戊酸基光动力疗法(PDT)的联合应用可通过提高原卟啉 IX(PpIX)光敏剂水平和细胞死亡来改善临床反应。在这里,我们表明,除了先前已知的作用外,5FU 还可增强 PDT 诱导的肿瘤消退免疫。在用氨基酮戊酸处理之前,用局部 5FU 或载体处理鼠光化性角化病 3 天,然后用蓝光照射(~417nm)。采集病变进行先天免疫细胞向病变内募集的时间过程分析,即中性粒细胞(Ly6G+)和巨噬细胞(F4/80+),分别在 PDT 后 72 小时和 1 周达到高峰,并且在 5FU 处理的病变中更大。在整个时间过程中,活化的 T 细胞(CD3+)和细胞毒性 T 细胞(CD8+)的浸润增强,在 PDT 后 1-2 周出现。5FU 预处理可减少在 PDT 后约 72 小时表达免疫检查点标志物 PD-1 的细胞的存在,有利于细胞毒性 T 细胞的活性。5FU 和 PDT 的联合应用,各自在除了对癌细胞的更直接影响之外,还能诱导长期的肿瘤靶向免疫反应,可能会协同作用,为鳞状前病变提供更好的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/0ef1f3a3db9c/nihms-1912501-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/54a0880ccd2a/nihms-1912501-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/ab7a6bbd6c4b/nihms-1912501-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/146f41c66576/nihms-1912501-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/0ef1f3a3db9c/nihms-1912501-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/54a0880ccd2a/nihms-1912501-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/ab7a6bbd6c4b/nihms-1912501-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/146f41c66576/nihms-1912501-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e15/10319084/0ef1f3a3db9c/nihms-1912501-f0011.jpg

相似文献

1
Combination of 5-Fluorouracil with Photodynamic Therapy: Enhancement of Innate and Adaptive Immune Responses in a Murine Model of Actinic Keratosis.5-氟尿嘧啶联合光动力疗法:在光化性角化病小鼠模型中增强固有和适应性免疫应答。
Photochem Photobiol. 2023 Mar;99(2):437-447. doi: 10.1111/php.13706. Epub 2022 Sep 20.
2
Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer.维生素 D 与光动力疗法联合增强了鳞状细胞皮肤癌小鼠模型的免疫反应。
Photodiagnosis Photodyn Ther. 2024 Feb;45:103983. doi: 10.1016/j.pdpdt.2024.103983. Epub 2024 Jan 27.
3
5-Fluorouracil Enhances Protoporphyrin IX Accumulation and Lesion Clearance during Photodynamic Therapy of Actinic Keratoses: A Mechanism-Based Clinical Trial.5-氟尿嘧啶增强光动力疗法治疗光化性角化病时原卟啉 IX 的积累和皮损清除:基于机制的临床试验。
Clin Cancer Res. 2018 Jul 1;24(13):3026-3035. doi: 10.1158/1078-0432.CCR-17-2020. Epub 2018 Mar 28.
4
Painless Photodynamic Therapy Triggers Innate and Adaptive Immune Responses in a Murine Model of UV-induced Squamous Skin Pre-cancer.无痛光动力疗法在 UV 诱导的鳞状皮肤癌前病变的小鼠模型中引发先天和适应性免疫反应。
Photochem Photobiol. 2021 May;97(3):607-617. doi: 10.1111/php.13350. Epub 2020 Nov 22.
5
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.紫外线照射和光动力治疗后皮肤肿瘤的发生不受5-氟尿嘧啶、咪喹莫特和卡泊三醇短期预处理的影响。一项无毛小鼠实验研究。
J Photochem Photobiol B. 2016 Jan;154:34-9. doi: 10.1016/j.jphotobiol.2015.11.009. Epub 2015 Nov 30.
6
5-Aminolevulinic acid photodynamic therapy with and without Er:YAG laser for actinic keratosis: Changes in immune infiltration.5-氨基酮戊酸光动力疗法联合或不联合铒:钇铝石榴石激光治疗光化性角化病:免疫浸润的变化。
Photodiagnosis Photodyn Ther. 2019 Jun;26:270-276. doi: 10.1016/j.pdpdt.2019.04.010. Epub 2019 Apr 12.
7
In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC.体外氟尿嘧啶耐药会导致 SCC 的光动力疗法损伤增强和 BCC 的肿瘤耐药。
J Photochem Photobiol B. 2022 Aug;233:112483. doi: 10.1016/j.jphotobiol.2022.112483. Epub 2022 May 29.
8
Improving the efficacy of photodynamic therapy for actinic keratosis: A comprehensive review of pharmacological pretreatment strategies.提高光动力疗法治疗光化性角化病的疗效:药理学预处理策略的综合评价。
Photodiagnosis Photodyn Ther. 2023 Sep;43:103703. doi: 10.1016/j.pdpdt.2023.103703. Epub 2023 Jul 8.
9
Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.对0.5%氟尿嘧啶乳膏和ALA-PDT序贯疗法治疗光化性角化病进行前瞻性、基于病例的评估。
J Drugs Dermatol. 2011 Apr;10(4):372-8.
10
Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.光化性角化病皮损的治疗前原卟啉IX浓度可能是基于氨基乙酰丙酸的光动力疗法反应的预测生物标志物。
Photodiagnosis Photodyn Ther. 2015 Dec;12(4):561-6. doi: 10.1016/j.pdpdt.2015.10.006. Epub 2015 Oct 22.

引用本文的文献

1
Enhancing antitumour immunity with photodynamic therapy.用光动力疗法增强抗肿瘤免疫力。
Photochem Photobiol Sci. 2025 Feb;24(2):227-234. doi: 10.1007/s43630-025-00690-2. Epub 2025 Feb 19.
2
Topical Immunotherapy for Actinic Keratosis and Field Cancerization.光化性角化病和场癌化的局部免疫疗法。
Cancers (Basel). 2024 Mar 12;16(6):1133. doi: 10.3390/cancers16061133.
3
Photodynamic Therapy and Adaptive Immunity Induced by Reactive Oxygen Species: Recent Reports.光动力疗法与活性氧诱导的适应性免疫:近期报道

本文引用的文献

1
Clinical and histopathological study of actinic keratosis treatment with photodynamic therapy VS 5-fluorouracil for face cancerization.光动力疗法与5-氟尿嘧啶治疗面部癌前病变日光性角化病的临床与组织病理学研究
Photodiagnosis Photodyn Ther. 2022 Sep;39:102967. doi: 10.1016/j.pdpdt.2022.102967. Epub 2022 Jun 15.
2
Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment: An interventional cohort-controlled trial.口服维生素 D 预处理联合蓝光光动力疗法治疗面部光化性角化病的疗效观察:一项介入性队列对照研究。
J Am Acad Dermatol. 2022 Jul;87(1):80-86. doi: 10.1016/j.jaad.2022.02.067. Epub 2022 Mar 18.
3
Cancers (Basel). 2024 Feb 28;16(5):967. doi: 10.3390/cancers16050967.
4
Treatment of nonmelanoma skin cancer with pro-differentiation agents and photodynamic therapy: Preclinical and clinical studies (Review).促分化剂和光动力疗法治疗非黑素瘤皮肤癌:临床前和临床研究(综述)。
Photochem Photobiol. 2024 Nov-Dec;100(6):1541-1560. doi: 10.1111/php.13914. Epub 2024 Feb 4.
5
Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer.维生素 D 与光动力疗法联合增强了鳞状细胞皮肤癌小鼠模型的免疫反应。
Photodiagnosis Photodyn Ther. 2024 Feb;45:103983. doi: 10.1016/j.pdpdt.2024.103983. Epub 2024 Jan 27.
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.
免疫检查点阻断对黑色素瘤患者髓源性抑制细胞群体的影响。
Front Immunol. 2021 Oct 12;12:740890. doi: 10.3389/fimmu.2021.740890. eCollection 2021.
4
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186.帕博利珠单抗(MK-3475)联合化疗治疗晚期结直肠癌的多中心、单臂、Ib 期研究:HCRN GI14-186。
Cancer Immunol Immunother. 2021 Nov;70(11):3337-3348. doi: 10.1007/s00262-021-02986-5. Epub 2021 Jun 23.
5
Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review).光动力、光热或电离辐射疗法联合免疫检查点抑制治疗实体瘤的当前前景(综述)
Pharmaceuticals (Basel). 2021 May 10;14(5):447. doi: 10.3390/ph14050447.
6
Emerging concepts in PD-1 checkpoint biology.PD-1 检查点生物学的新观点。
Semin Immunol. 2021 Feb;52:101480. doi: 10.1016/j.smim.2021.101480. Epub 2021 May 15.
7
Non-Oncologic Applications of Nanomedicine-Based Phototherapy.基于纳米医学的光疗在非肿瘤学中的应用。
Biomedicines. 2021 Jan 25;9(2):113. doi: 10.3390/biomedicines9020113.
8
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
9
Targeting immunogenic cell death in cancer.针对癌症的免疫原性细胞死亡。
Mol Oncol. 2020 Dec;14(12):2994-3006. doi: 10.1002/1878-0261.12851. Epub 2020 Dec 1.
10
Painless Photodynamic Therapy Triggers Innate and Adaptive Immune Responses in a Murine Model of UV-induced Squamous Skin Pre-cancer.无痛光动力疗法在 UV 诱导的鳞状皮肤癌前病变的小鼠模型中引发先天和适应性免疫反应。
Photochem Photobiol. 2021 May;97(3):607-617. doi: 10.1111/php.13350. Epub 2020 Nov 22.